Browsing: GLP1

Credit: selvanegra/ Getty Images A study completed by PrecisionLife and Ovation.io has uncovered genetic biomarkers that predict whether someone is…

New weight-loss drugs promise deeper results and reshape obesity care, but also raise questions for health, ethics and longevity. For…

Below is an approximation of this video’s audio content. To see any graphs, charts, graphics, images, and quotes to which…

Preventive health offering combines ‘microdosed’ GLP-1 meds with biomarker monitoring and behavior change guidance. Digital health platform Noom is broadening…

Credit: CIPhotos / iStock / Getty Images Plus An analysis of nearly 50 randomized controlled trials has found no link…

Credit: selvanegra/ Getty Images Research led by National Cheng Kung University, Taiwan, suggests glucagon-like peptide 1 (GLP-1) receptor agonists can…

The WHO warns that the current production levels of GLP-1 therapies are insufficient to equitably provide care for the billion…

November’s highlights include a spike in global debates over ultra-processed foods (UPFs), US nutrition assistance, Nestlé’s dismissal of added sugar…

Long shot Phase 3 trial finds semaglutide did not deliver a statistically significant reduction in Alzheimer’s progression. Pharma giant Novo…

Credit: Juan Gaertner/Science Photo Library/Getty Images The results from two Phase III trials announced this week show Novo Nordisk’s GLP-1…